Antimicrobial use: Risk driver of multidrug resistant microorganisms in healthcare settings

Current Opinion in Infectious Diseases

Volumn 22, Issue 4, 2009, Pages 352-358

  Tacconelli, Evelina ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antibiotic; Antibiotic resistance; Antibiotic stewardship; Evidence based medicine

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; LINEZOLID; MACROLIDE; POLYPEPTIDE ANTIBIOTIC AGENT; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; DRUG USE; ENTEROCOCCAL INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENETIC HETEROGENEITY; HUMAN; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REVIEW; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GUIDELINES AS TOPIC; HEALTH FACILITIES; HUMANS; SELECTION (GENETICS);

EID: 67651112200     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32832d52e0     Document Type: Review

References (52)

1. Song JY, Cheong HJ, Jo YM, et al. Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis. Am J Infect Control 2009 [Epub ahead of print].
2. Tacconelli E, De Angelis G, Cataldo MA, et al. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008; 61:26-38.
3. Matthaiou DK, Michalopoulos A, Rafailidis PI, et al. Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: a matched case-control study. Crit Care Med 2008; 36:807-811.
4. Rodríguez-Baño J, Navarro MD, Romero L, et al. Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Clin Microbiol Infect 2008; 14:180-183.
5. Davey P, Brown E, Fenelon L, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2005: CD003543.
6. Fowler VG Jr, Boucher HW, Corey GR, et al., S. aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355:653-665.
7. Tacconelli E, De Angelis G, Cataldo MA, et al. Usage of carbapenems significantly increases the rate of new colonisation due to antibiotic-resistant bacteria in hospitalised patients. Presented at 18th European Congress of Clinical Microbiology and Infectious Diseases; 19-22 April 2008; Barcelona.
8. de Bruin MA, Riley LW. Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review. BMC Infect Dis 2007; 10:7-24.
9. MacAdam H, Zaoutis TE, Gasink LB, et al. Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic use. Int J Antimicrob Agents 2006; 28:325-332.
10. Carmeli Y, Samore MH, Huskins C. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. Arch Intern Med 1999; 159:2461-2468.
11. Tacconelli E, Cataldo MA, De Pascale G, et al. Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. J Antimicrob Chemother 2008; 62:1130-1137.
12. Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 2008; 13:pii:19045.
13. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003; 36:1103-1110.
14. Aldeyab MA, Monnet DL, Ló pez-Lozano JM, et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother 2008; 62:593-600. Authors built a multivariate ARIMA (time-series analysis) model to relate MRSA incidence with antibiotic use and infection control practices. Temporal variations in MRSA incidence followed temporal variations in the use of fluoroquinolones, third-generation cephalosporins, macrolides and amoxicillin/clavulanic acid.
15. European Antimicrobial Resistance Surveillance System. Susceptibility results for S. aureus isolates in 2007. Available at: http://www.rivm.nl/earss/ database/. [Accessed 1 March 2009]
16. Bisognano C, Vaudaux PE, Lew DP, et al. Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 1997; 41:906-913.
17. Hoiby N, Jarlov JO, Kemp M, et al. Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet 1997; 349:167-169.
18. Venezia RA, Domaracki BE, Evans AM, et al. Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure. J Antimicrob Chemother 2001; 48:375-381.
19. Kampf G, Adena S, Ruden H, Weist K. Inducibility and potential role of MecAgene-positive oxacillin-susceptible Staphylococcus aureus from colonized healthcare workers as a source for nosocomial infections. J Hosp Infect 2003; 54:124-129.
20. Schentag JJ, Hyatt JM, Carr JR, et al. Genesis of methicillin-resistant Staphy-lococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clin Infect Dis 1998; 26:1204-1214.
21. Stone SP, Beric V, Quick A, et al. The effect of an enhanced infection-control policy on the incidence of Clostridium difficile infection and methicillin-resistant Staphylococcus aureus colonization in acute elderly medical patients. Age Ageing 1998; 27:561-568.
22. Jones JC, Rogers TJ, Brookmeyer P, et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 2007; 45:541-547.
23. Tacconelli E, Cataldo MA. Vancomycin-resistant enterococci (VRE): transmission and control. Int J Antimicrob Agents 2008; 31:99-106.
24. Furuno JP, McGregor JC, Harris AD, et al. Identifying groups at high risk for carriage of antibiotic-resistant bacteria. Arch Intern Med 2006; 166:580-585.
25. Donskey CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000; 343:1925-1932.
26. D'Agata EM, Gautam S, Green WK, Tang YW. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis 2002; 34:167-172.
27. Quale J, Landman D, Saurina G, et al. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996; 23:1020-1025.
28. Smith DW. Decreased antimicrobial resistance after changes in antibiotic use. Pharmacotherapy 1999; 19:129S-132S.
29. D'Agata EM, Webb G, Horn M. A mathematical model quantifying the impact of antibiotic exposure and other interventions on the endemic prevalence of vancomycin-resistant enterococci. J Infect Dis 2005; 192:2004-2011.
30. Pogue JM, Paterson DL, Pasculle AW, Potoski BA. Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2007; 28:1382-1388.
31. Ortega M, Marco F, Soriano A, et al. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother 2009; 63:568-574.
32. Lautenbach E, Metlay JP, Weiner MG, et al. Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance. Infect Control Hosp Epidemiol 2009; 30:18-24.
33. Lipworth AD, Hyle EP, Fishman NO, et al. Limiting the emergence of extended-spectrum beta-lactamase-producing Enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect Control Hosp Epidemiol 2006; 27:279-286.
34. Kaye KS, Harris AD, Samore M, Carmeli Y. The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect Control Hosp Epidemiol 2005; 26:346-351.
35. Harris AD, Samore MH, Lipsitch M, et al. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli. Clin Infect Dis 2002; 34:1558-1563.
36. Hyle EP, Bilker WB, Gasink LB, Lautenbach E. Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection. Infect Control Hosp Epidemiol 2007; 28:647-654.
37. D'Agata E, Venkataraman L, DeGirolami P, Samore M. The molecular epidemiology of acquisition of ceftazidime-resistant Gram-negative strains in a nonoutbreak setting. J Clin Microbiol 1997; 35:2602-2605.
38. D'Agata EM, Cataldo MA, Cauda R, Tacconelli E. The importance of addressing multidrug resistance and not assuming single-drug resistance in case-control studies. Infect Control Hosp Epidemiol 2006; 27:670-674.
39. Bonten MJ, Slaughter S, Ambergen AW, et al. The role of 'colonization pressure' in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998; 158:1127-1132.
40. Harbarth S, Samore MH. Interventions to control MRSA: high time for time-series analysis? J Antimicrob Chemother 2008; 62:431-433. Useful review on intervention studies to decrease methicillin-resistant Staphyloccoccus aureus rates by active antibiotic policies.
41. Fishman N. Antimicrobial steawrdship. Am J Med 2006; 119:553-561.
42. Owens RC. Antimicrobial stewardship: concepts and strategies in the 21st centrury. Diagn Microbiol Infect Dis 2008; 61:110-128. Review of the evidence on programs for optimizing antimicrobial use and efficacy of antimicrobial stewardship programs.
43. Johannes RS. Epidemiology of early-onset bloodstream infection and implications for treatment. Am J Infect Control 2008; 36:S171.e13-S171.e17.
44. Kang CI, Kim SH, Park WB, et al. Bloodstream infections caused by antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of in-appropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005; 49:760-766.
45. Apisarnthanarak A, Kiratisin P, Mundy LM. Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes. Infect Control Hosp Epidemiol 2008; 29:1026-1034.
46. Smith RL, Evans HL, Chong TW, et al. Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit. Surg Infect (Larchmt) 2008; 9:423-431.
47. Kim JY, Sohn JW, Park DW, et al. Control of extended-spectrum {beta}-lactamase-producing Klebsiella pneumonite using a computer-assisted management program to restrict third-generation cephalosporin use. J Antimicrob Chemother 2008; 62:416-421. Ambidirectional intervention study. Hospital-wide restriction of third-generation cephalosporin use was integrated into a preexisting computerized antibiotic prescription program. The proportion of ESBL-producing K. pneumoniae, imipenem- or piperacillin/tazobactam- resistant Pseudomonas aeruginosa, and Acinetobacter baumannii isolates decreased significantly over the study period.
48. Lee J, Pai H, Kim YK, et al. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother 2007; 60:629-637.
49. Cadena J, Taboada CA, Burgess DS, et al. Antibiotic cycling to decrease bacterial antibiotic resistance: a 5-year experience on a bone marrow transplant unit. Bone Marrow Transplant 2007; 40:151-155.
50. Madaras-Kelly KJ, Remington RE, Lewis PG, Stevens DL. Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infect Control Hosp Epidemiol 2006; 27:155-169.
51. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44:159-177.
52. Borg MA, Cookson BD, Rasslan O, et al. Correlation between meticillin-resistant Staphylococcus aureus prevalence and infection control initiatives within southern and eastern Mediterranean hospitals. J Hosp Infect 2009; 71:36-42.